دورية أكاديمية

GSK-3 inhibitor elraglusib (9-ING-41) to enhance tumor-infiltrating immune cell activation in tumor biopsies and synergize with anti-PD-L1 in a murine model of colorectal cancer.

التفاصيل البيبلوغرافية
العنوان: GSK-3 inhibitor elraglusib (9-ING-41) to enhance tumor-infiltrating immune cell activation in tumor biopsies and synergize with anti-PD-L1 in a murine model of colorectal cancer.
المؤلفون: El-Deiry, Wafik S., Huntington, Kelsey, Louie, Anna, Srinivasan, Praveen, Schorl, Cristoph, Lu, Shaolei, Silverberg, David, Newhouse, Daniel, Wu, Zhijin, Zhou, Lanlan, Ryspayeva, Dinara, Borden, Brittany, Giles, Francis J., Dooner, Mark, Carneiro, Benedito A.
المصدر: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pe15138-e15138, 1p
قاعدة البيانات: Supplemental Index
ResultId 1
Header edo
Supplemental Index
164015957
897
6
Academic Journal
academicJournal
896.761413574219
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=164015957&custid=s6537998&authtype=sso
FullText Array ( [Availability] => 0 )
Items Array ( [Name] => Title [Label] => Title [Group] => Ti [Data] => GSK-3 inhibitor elraglusib (9-ING-41) to enhance tumor-infiltrating immune cell activation in tumor biopsies and synergize with anti-PD-L1 in a murine model of colorectal cancer. )
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22El-Deiry%2C+Wafik+S%2E%22">El-Deiry, Wafik S.</searchLink><br /><searchLink fieldCode="AR" term="%22Huntington%2C+Kelsey%22">Huntington, Kelsey</searchLink><br /><searchLink fieldCode="AR" term="%22Louie%2C+Anna%22">Louie, Anna</searchLink><br /><searchLink fieldCode="AR" term="%22Srinivasan%2C+Praveen%22">Srinivasan, Praveen</searchLink><br /><searchLink fieldCode="AR" term="%22Schorl%2C+Cristoph%22">Schorl, Cristoph</searchLink><br /><searchLink fieldCode="AR" term="%22Lu%2C+Shaolei%22">Lu, Shaolei</searchLink><br /><searchLink fieldCode="AR" term="%22Silverberg%2C+David%22">Silverberg, David</searchLink><br /><searchLink fieldCode="AR" term="%22Newhouse%2C+Daniel%22">Newhouse, Daniel</searchLink><br /><searchLink fieldCode="AR" term="%22Wu%2C+Zhijin%22">Wu, Zhijin</searchLink><br /><searchLink fieldCode="AR" term="%22Zhou%2C+Lanlan%22">Zhou, Lanlan</searchLink><br /><searchLink fieldCode="AR" term="%22Ryspayeva%2C+Dinara%22">Ryspayeva, Dinara</searchLink><br /><searchLink fieldCode="AR" term="%22Borden%2C+Brittany%22">Borden, Brittany</searchLink><br /><searchLink fieldCode="AR" term="%22Giles%2C+Francis+J%2E%22">Giles, Francis J.</searchLink><br /><searchLink fieldCode="AR" term="%22Dooner%2C+Mark%22">Dooner, Mark</searchLink><br /><searchLink fieldCode="AR" term="%22Carneiro%2C+Benedito+A%2E%22">Carneiro, Benedito A.</searchLink> )
Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pe15138-e15138, 1p )
RecordInfo Array ( [BibEntity] => Array ( [Identifiers] => Array ( [0] => Array ( [Type] => doi [Value] => 10.1200/JCO.2023.41.16_suppl.e15138 ) ) [Languages] => Array ( [0] => Array ( [Code] => eng [Text] => English ) ) [PhysicalDescription] => Array ( [Pagination] => Array ( [PageCount] => 1 [StartPage] => e15138 ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => GSK-3 inhibitor elraglusib (9-ING-41) to enhance tumor-infiltrating immune cell activation in tumor biopsies and synergize with anti-PD-L1 in a murine model of colorectal cancer. [Type] => main ) ) ) [BibRelationships] => Array ( [HasContributorRelationships] => Array ( [0] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => El-Deiry, Wafik S. ) ) ) [1] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Huntington, Kelsey ) ) ) [2] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Louie, Anna ) ) ) [3] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Srinivasan, Praveen ) ) ) [4] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Schorl, Cristoph ) ) ) [5] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Lu, Shaolei ) ) ) [6] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Silverberg, David ) ) ) [7] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Newhouse, Daniel ) ) ) [8] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Wu, Zhijin ) ) ) [9] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Zhou, Lanlan ) ) ) [10] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Ryspayeva, Dinara ) ) ) [11] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Borden, Brittany ) ) ) [12] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Giles, Francis J. ) ) ) [13] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Dooner, Mark ) ) ) [14] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Carneiro, Benedito A. ) ) ) ) [IsPartOfRelationships] => Array ( [0] => Array ( [BibEntity] => Array ( [Dates] => Array ( [0] => Array ( [D] => 02 [M] => 06 [Text] => 2023 Supplement 16 [Type] => published [Y] => 2023 ) ) [Identifiers] => Array ( [0] => Array ( [Type] => issn-print [Value] => 0732183X ) ) [Numbering] => Array ( [0] => Array ( [Type] => volume [Value] => 41 ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Journal of Clinical Oncology [Type] => main ) ) ) ) ) ) )
IllustrationInfo